beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.
about
Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell deathThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Vanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice.Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Nanoparticle and iron chelators as a potential novel Alzheimer therapy.Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.F3-Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegansAn update on using vitamin E in Alzheimer's disease.Undifferentiated and differentiated PC12 cells protected by huprines against injury induced by hydrogen peroxideQuantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain agingCharacterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's diseaseGenetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron proteinProtective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Neurite Outgrowth and Neuroprotective Effects of Quercetin from Caesalpinia mimosoides Lamk. on Cultured P19-Derived NeuronsAmyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity.Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.Synthesis and antioxidant activities of novel 5-chlorocurcumin, complemented by semiempirical calculations.Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's diseaseAnthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1-42-induced oxidative stress.Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.Melatonin as a natural ally against oxidative stress: a physicochemical examination.Vibrational spectroscopy of biofluids for disease screening or diagnosis: translation from the laboratory to a clinical setting.Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders.Scavengers of reactive γ-ketoaldehydes extend Caenorhabditis elegans lifespan and healthspan through protein-level interactions with SIR-2.1 and ETS-7.Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes.Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics studyProtective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's diseaseDistribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.
P2860
Q24795759-5F84CC67-79B3-43FD-A14F-BFDCE4C22EA0Q26827320-5DAF77E0-576B-4F2B-80A7-788C5252E492Q27693922-57697AA1-8B25-4D5E-9745-80F6B84C7008Q30446460-F013D4F5-2AF9-4CD6-9C93-F77C5AF34855Q30835280-12C81F12-8DBE-4699-8A36-60CADD5E4BCDQ32063594-FC1365DE-2CF4-489F-A6A5-F2912B30AEFFQ33552777-1FCB9E1A-13C9-4D0A-9235-3EFFCF9706E8Q33639885-88D3B09E-F9D1-4F22-BE84-268FC01A32BEQ33720596-4B211340-1D8A-4541-9A38-E5A84F702366Q33854028-3F155BEC-E9C2-4622-A37C-1B85250B9B1FQ34094516-D8150DBF-FACB-4C39-B759-5FE8A9E75BBDQ34556705-26B5224B-CAE1-4F07-B0B2-98BFAD830B1AQ34592437-2F20375C-E790-48A1-9BAD-56D8EAB7B056Q34616619-88F301D7-EB08-4A32-9F5E-B638E8B90BBFQ35004992-F668C3AC-A3EA-4E4B-870F-7B9E827B887FQ35059268-F2B48F89-7F38-4548-8E07-DA99B6555AF1Q35359185-56429FC0-AFCF-4E2A-AC1B-818141BC8F73Q35537887-EA849A53-3F4E-49DE-90A2-5EC18152F2A7Q35607880-940DD27F-DBE0-45B3-AE24-DF9CE0554104Q35810038-9359FCF0-C0D4-4AED-8437-DDAA212B5D8AQ36075555-646E365F-8A8F-497C-B986-09D167EDB429Q36076365-5C4E53BA-13D8-4422-8018-4363BC3E5ABAQ36956015-73792996-E27A-41F9-95DB-318942F83D02Q37111515-B9076F02-7AB8-4203-8DF2-2550498715EDQ37124409-38BBCD2A-7363-415F-8F2A-4C0487220CCAQ37133480-61CA239E-074E-4528-A0F0-EBB245B564F1Q37213394-260D6519-D843-4039-AF44-277666A008F7Q37221904-D7FC4385-49B7-4EDF-9743-B3F2FF9AD5A0Q37428097-AC1D5720-6292-4BC3-9543-1B435B8CDA6AQ37631022-C241E430-680C-42A9-B27C-1C72AC6423CDQ37670716-31D2BB3B-0BD1-4699-BCEE-76AAC5B865DAQ37900675-FC400EE2-AA06-4BE9-B3AA-426E3B34487BQ38197570-FAD5B0E6-6359-495E-8BE4-D17F5124097EQ38528923-83FCA275-77A0-4728-8B9F-7845DC0C510AQ39499402-A2AD16E8-E744-4514-B395-2BFACC170731Q40679922-8D4152E6-11B3-453C-A309-7791C05FCE6CQ41870228-959562B1-8EE0-4778-A45B-E662E3E769FCQ41975964-197C9346-8EF1-41C3-90FF-CC79FC2168AFQ42720973-EE44515E-7299-4EE4-838A-85ED9827FC5BQ42920869-D11316E2-8652-4267-AF5D-9B780F77547E
P2860
beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
beta-Amyloid-associated free r ...... tions for Alzheimer's disease.
@en
type
label
beta-Amyloid-associated free r ...... tions for Alzheimer's disease.
@en
prefLabel
beta-Amyloid-associated free r ...... tions for Alzheimer's disease.
@en
P356
P1476
beta-Amyloid-associated free r ...... tions for Alzheimer's disease.
@en
P2093
Butterfield DA
P304
P356
10.1021/TX960130E
P577
1997-05-01T00:00:00Z